Département de Radiothérapie, Centre Alexis Vautrin, Nancy, France.
Eur J Cancer. 2013 Apr;49(6):1314-23. doi: 10.1016/j.ejca.2012.12.005. Epub 2013 Feb 8.
To evaluate both local outcome and sequelae of non-metastatic spinal Ewing tumours (EWT).
A French cohort of patients ≤ 50years with localised spinal EWT treated between 1988 and 2009, was analysed in regard to tumour characteristics (e.g. volume, vertebral compartment, spinal cord compression, paraspinal soft tissue invasion), local treatment modalities (surgery (S) and margin quality, radiotherapy (RT) dose), response to treatment (e.g. histological response to neoadjuvant chemotherapy (CT)), tumour local control (LC) and sequelae.
Seventy-five patients treated in successive trials were evaluated for LC: SFOP-EW88 (n=14), SFOP-EW93 (n=17) and EuroEwing99 (n=44). Fifty-seven patients (79%) presented initial neurological compression and 69% had inaugural decompressive S. Local treatment modality was S+RT (n=50), RT alone (n=19) and S alone (n=6). Surgery was mainly intralesional (66%). Local recurrences had occurred in 19 patients (14 local, 5 loco-regional) with a median interval of 25 months (1-50). After a 7 year median follow-up (1-22 years), the 5-year LC, relapse-free survival (RFS) and overall survival (OS) reached 78.0% (95%CI: 62.6-84.6), 57.0% (95%CI: 45.2-68.9) and 70.0% (95%CI: 59.1-81.0), respectively. Vertebral compartment involved was the only prognostic factor (5-year LC rate 100% versus 71% for favourable and unfavourable compartment, p<0.03). Among 41 five-year survivors, we observed spinal curvature deformation (35%), growth retardation (28%), spinal reduction mobility (40%), spinal pain (25%) and neurological sequelae (32%) without any significant association with a particular local procedure.
RT is the backbone of a successful local treatment of spinal EWT. The place of S remains a pending question. Its actual benefit will likely evolve with new available RT techniques.
评估非转移性脊柱尤因肉瘤(EWT)的局部疗效和后遗症。
对 1988 年至 2009 年间在法国接受局部脊柱 EWT 治疗的 ≤ 50 岁患者的队列进行了分析,评估了肿瘤特征(如体积、椎体节段、脊髓压迫、椎旁软组织侵犯)、局部治疗方法(手术(S)和切缘质量、放疗(RT)剂量)、治疗反应(如新辅助化疗(CT)的组织学反应)、肿瘤局部控制(LC)和后遗症。
在连续的试验中,对 75 例患者进行了 LC 评估:SFOP-EW88(n=14)、SFOP-EW93(n=17)和 EuroEwing99(n=44)。57 例(79%)患者有初始神经压迫,69%患者有初始减压 S。局部治疗方式为 S+RT(n=50)、RT 单独治疗(n=19)和 S 单独治疗(n=6)。手术主要为局限性(66%)。19 例患者(14 例局部复发,5 例局部区域复发)发生局部复发,中位间隔时间为 25 个月(1-50)。中位随访 7 年(1-22 年)后,5 年 LC、无复发生存率(RFS)和总生存率(OS)分别达到 78.0%(95%CI:62.6-84.6)、57.0%(95%CI:45.2-68.9)和 70.0%(95%CI:59.1-81.0)。受累椎体节段是唯一的预后因素(5 年 LC 率为 100%,而良好和不良节段分别为 71%,p<0.03)。在 41 例 5 年幸存者中,我们观察到脊柱弯曲变形(35%)、生长迟缓(28%)、脊柱活动度降低(40%)、脊柱疼痛(25%)和神经后遗症(32%),但与特定的局部手术无明显相关性。
RT 是脊柱 EWT 成功局部治疗的基础。S 的位置仍是一个悬而未决的问题。随着新的 RT 技术的出现,其实际益处可能会发生变化。